Market Insights
Growing rates of spinal injuries such as degenerative disc disease or deformity have propelled the rise in investments in research activities by industrial players for the treatment and stabilization of the thoracolumbar spine. According to spinal cord.com, around 2,45,000 to 3,53,000 Americans were projected to live with spinal cord injuries in 2017. Traditional open surgeries require a prolonged hospital stay and are extensively painful. The need for new minimally invasive technology is increasing among healthcare providers and patients. Simplifying spinal surgeries is on the rise, thus contributing to the overall growth of the thoracolumbar spine devices market.
The FDA granted 510(k) clearance for the PEEK-OPTIMA HA enhanced vertebral body replacement system on December 7, 2017. Using spacers and endplates, the device allows for fine height and lordosis adjustments. It also consists of a hollow center and holes to accommodate an autograft and encourage the growth of new bone. On October 25, 2017, Zimmer Biomet Holdings, Inc. launched Vitality+ and Vital Spinal Fixation Systems in the United States. The Vital Spinal Fixation System offers a compact solution for degenerative thoracolumbar procedures. The advent of such new technologies and continuous research initiatives ensures lucrativeness throughout the period from 2018 to 2026.
Implant devices are expected to contribute significantly to the overall market owing to their lower side effects, improved quality of life, and high preference for the geriatric population, which is prone to spinal diseases. However, highly-priced devices and procedures, the requirement of skilled healthcare professionals, and the lack of structured reimbursement policies in low and middle-income economies would hamper the geographic expansion of the thoracolumbar spinal devices market and negatively affect the overall market growth.
The global thoracolumbar spine devices market is segmented as follows:
By Product Type
- Vertebral Body Replacement System
- MACS TL/MACS II system
- Spinal System
- Spondylolisthesis Reduction Instrumentation (SRI)
- Fracture Reduction Instrumentation (FRI)
- Bone Transforaminal, Anterior, and Posterior Lumbar Interbody Fusion
- Standalone Interbody Device (SIBD) Spinal System
- Micro Lumbar Discectomy (MLD) Retractor System
- CASPAR Lumbar Retractor (CLR) System
- Others (Artificial Disc, Retractor System, etc.)
By Geography
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The thoracolumbar spinal devices market comprises a competitive pool with various market leaders enjoying supremacy. Partnerships and acquisitions render the market competitive and challenge the entry of new emerging market players. On September 7, 2017, NuVasive, Inc. acquired Vetera Spine. The acquisition reflected NuVasive’s commitment to expanding its product portfolio and marked its position as a leader in spinal devices. Other key industrial players enjoying a dominant position in this market are Aesculap Implant Systems, LLC, B. Braun Melsungen AG, DePuy Synthes, Inc., Globus Medical, Inc., Invibo Ltd., Medtronic Plc., Stryker Corp., and Zimmer Biomet Holdings, Inc.
This report offers the following:
- An overview of the global thoracolumbar spine devices market
- Market trends and extensive analysis are provided for the forecast period from 2018 to 2026, along with historical data for 2016 and considering 2017 as the base year.
- Market evaluation pertaining to each segment
- Qualitative information with respect to market drivers, opportunities, and restraints
- Detailed information on the existing thoracolumbar spine device manufacturers
- A complete understanding of the competitive landscape and profiles of key market players
